樂觀
$2.52
情境價格
$1.330
+0.031 (+2.31%)收盤時
Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace.
Currently, Akso Health Group (AHG) is not a strong buy. The stock is trading at $1.30, which is significantly below its 200-day simple moving average of $1.516, indicating a bearish trend. Additionally, the stock has a negative forward P/E ratio of 0, suggesting uncertainty about future earnings. While the RSI is at 58.02, indicating potential for upward momentum, the recent 5-day change is -3.70%, reflecting short-term weakness. The main risk is the stock's high price-to-sales ratio of 75.56, which indicates it may be overvalued compared to its sales performance.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Akso Health Launches Brain-Computer Interface R&D Program

Akso Health Initiates Brain-Computer Interface R&D Program

U.S. Stocks Rise as NIO Reports Strong Earnings

U.S. Stocks Mixed in Morning Trading

Ingram Micro Reports Strong Quarterly Earnings, Shares Surge
Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).
Currently, Akso Health Group (AHG) is not a strong buy. The stock is trading at $1.30, which is significantly below its 200-day simple moving average of $1.516, indicating a bearish trend. Additionally, the stock has a negative forward P/E ratio of 0, suggesting uncertainty about future earnings. While the RSI is at 58.02, indicating potential for upward momentum, the recent 5-day change is -3.70%, reflecting short-term weakness. The main risk is the stock's high price-to-sales ratio of 75.56, which indicates it may be overvalued compared to its sales performance.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。